Plus   Neg

Sartorius H1 Profit Climbs, Lifts FY19 Sales View, Backs Margin Forecast

Sartorius AG (SDMHF.PK), a German laboratory and pharmaceutical equipment provider, reported Friday that its first-half net profit climbed 27.3 percent to 101.5 million euros from 79.8 million euros last year. Earnings per ordinary share were 1.48 euros, up from 1.16 euros a year ago.

Underlying EBITDA rose 25.4 percent to 237.6 million euros from 189.5 million euros a year ago. The Underlying EBITDA margin reached 26.6 percent after 25 percent in the year earlier.

Consolidated sales revenue in the first six months grew 18 percent from last year to 894.7 million euros. Sales revenue in constant currencies rose 15.9 percent.

Order intake increased 20.7 percent on a reported basis and 18.7 percent in constant currencies to 974.3 million euros.

Looking ahead, the company raised its sales forecast for fiscal 2019 based on strong business performance in the first half and continued high demand.

Group sales revenue for the full year is now projected to increase by about 10 percent to 14 percent in constant currencies compared to previous guidance of 7 percent to 11 percent.

The company continues to forecast that the underlying EBITDA margin will increase to slightly more than 27 percent.

For the Bioprocess Solutions Division, the company raised its sales guidance to growth of about 13 percent to 17 percent from its previous forecast of about 8 percent to 12 percent.

For the Lab Products & Services Division, Sartorius now anticipates that due to the softer economic environment, the lower range of the sales forecast of about 5 percent to 9 percent will be reached.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT